Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer is a phase 2, randomised interventional study registered as NCT06728072 by Virginia Commonwealth University, with a registry enrolment figure of 97 participants, started 2025-03-07 and due to reach its primary completion in 2035-07-01. Interventions recorded: Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin. Conditions listed: Colorectal Cancer; CRC. Primary outcome: Best response by analysis using Response Evaluation Criteria in Solid Tumors. Colorectal eligibility wording from the registry: "* Diagnosis of stage IV colorectal cancer". Sites: United States. No results are recorded here; the registry entry is the source.